ArticleBlood research2019

Clinical impacts of inflammatory markers and clinical factors in patients with relapsed or refractory diffuse large B-cell lymphoma.

Do-Young Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.